Exercise Program for ICD Users
(E-ICD Trial)
Trial Summary
What is the purpose of this trial?
This study will test an exercise intervention (E-ICD) following an implantable cardioverter defibrillator.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the E-ICD Intervention treatment for ICD users?
Is exercise generally safe for people with ICDs?
How does the E-ICD Intervention treatment differ from other treatments for ICD users?
The E-ICD Intervention is unique because it focuses on a structured exercise program specifically designed for people with implantable cardioverter defibrillators (ICDs), helping them safely engage in physical activity without fear of triggering a device shock. This approach is different from standard treatments, which may not emphasize exercise as a key component of managing ICD-related concerns.1112131415
Research Team
Cynthia M Dougherty, ARNP, PhD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for adults over 18 who have had an ICD implanted to prevent sudden cardiac arrest. Participants must be able to walk unassisted for 5-10 minutes a day, speak and write English, and have access to a reliable phone for at least six months.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the E-ICD intervention, a home-based exercise program, for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, with outcomes measured at 3, 6, and 12 months
Maintenance
Participants receive an exercise prescription to maintain and increase exercise levels over the ensuing 3 months
Treatment Details
Interventions
- E-ICD Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor